The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables

• P. Jimenez-Fonseca ^[1] ; C. Calderon ^[2] ; A. Carmona-Bayonas ^[10] ; M. M. Muñoz ^[3] ; R. Hernández ^[4] ; M. Mut Lloret ^[5] ; I. Ghanem ^[6] ; C. Beato ^[11] ; D. Cacho Lavín ^[7] ; A. Ivars Rubio ^[10] ; R. Carrión ^[8] ; C. Jara ^[9]
  1. [1] Hospital Universitario Central de Asturias

     Hospital Universitario Central de Asturias

     Oviedo, España

     
  2. [2] Universitat de Barcelona

     Universitat de Barcelona

     Barcelona, España

     
  3. [3] Hospital Virgen de La Luz de Cuenca

     Hospital Virgen de La Luz de Cuenca

     Cuenca, España

     
  4. [4] Hospital Universitario de Canarias

     Hospital Universitario de Canarias

     San Cristóbal de La Laguna, España

     
  5. [5] Hospital Universitario Son Espases

     Hospital Universitario Son Espases

     Palma de Mallorca, España

     
  6. [6] Hospital Universitario La Paz

     Hospital Universitario La Paz

     Madrid, España

     
  7. [7] Hospital Universitario Marqués de Valdecilla

     Hospital Universitario Marqués de Valdecilla

     Santander, España

     
  8. [8] Hospital Universitario del Sureste

     Hospital Universitario del Sureste

     Arganda del Rey, España

     
  9. [9] Fundación Hospital Alcorcón

     Fundación Hospital Alcorcón

     Alcorcón, España

     
  10. [10] Hospital Universitario Morales Meseguer, España
  11. [11] Hospital Universitario Virgen de La Macarena, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 11 (November 2018), 2018, págs. 1392-1399
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Dialnet Métricas: 1 Cita
• Resumen

  • Purpose The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients’ emotional distress, and coping in subjects with resected, non-metastatic cancer.

    Methods 602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants’ emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires.

    Results Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I–II (28 vs 18%).

    Conclusion Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients.